Stock listing

Xvivo Perfusion Ab

Selected listing: 0RKL · LSE · SEK · GB

Xvivo Perfusion Ab (LSE:0RKL), Health Technology. Latest release Sep 28, 2026: XVIVO announces FDA receipt of PMA application for the XVIVO Heart Assist…

0RKL:LSESEKGBUpdated October 3, 2026

Ticker: LSE:0RKL
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LSE
Currency: SEK

Latest news from Xvivo Perfusion Ab

XVIVO announces FDA receipt of PMA application for the XVIVO Heart Assist Transport System

September 28, 2026

XVIVO receives CE certificates for its groundbreaking heart preservation technology, transforming access to life-saving transplants across Europe

August 11, 2026

XVIVO granted additional patient enrollment in the US PRESERVE CAP study for XVIVO Heart Assist Transport

August 3, 2026

Interim Report January - June 2026

July 14, 2026

Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology

May 18, 2026

All Xvivo Perfusion Ab news →

Events

Replays

Xvivo Perfusion AB (publ) (XVIVO) Q2 2026 Earnings Call
Tue, Jul 14, 2026 · 07:00 AM ET
Watch
Xvivo Perfusion AB (publ) (XVIVO) Q1 2026 Earnings Call
Fri, Apr 24, 2026 · 09:00 AM ET
Watch
Xvivo Perfusion AB (publ) (XVIVO) Q4 2025 Earnings Call
Tue, Jan 27, 2026 · 08:00 AM ET
Watch

Research Xvivo Perfusion Ab

Xvivo Perfusion Ab company profile

View the public company page for Xvivo Perfusion Ab on 6ix.

Xvivo Perfusion Ab news

Read company news and market updates connected to Xvivo Perfusion Ab.

Xvivo Perfusion Ab investor events

Find investor webinars, events, and replay context for Xvivo Perfusion Ab.